Mackenzie Financial Corp Ginkgo Bioworks Holdings, Inc. Transaction History

Mackenzie Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $209,935 - $869,730	749,768 New	749,768 $247,000
Q2 2022 Aug 10, 2022	SELL	$2.2 - $4.2 $119,585 - $228,299	-54,357 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $3,381 - $10,384	1,195 Added 2.25%	54,357 $219,000
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $441,776 - $793,177	53,162 New	53,162 $442,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.